Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study.
Blink M, Zimmermann M, von Neuhoff C, Reinhardt D, de Haas V, Hasle H, O'Brien MM, Stark B, Tandonnet J, Pession A, Tousovska K, Cheuk DK, Kudo K, Taga T, Rubnitz JE, Haltrich I, Balwierz W, Pieters R, Forestier E, Johansson B, van den Heuvel-Eibrink MM, Zwaan CM.
Blink M, et al. Among authors: zimmermann m.
Haematologica. 2014 Feb;99(2):299-307. doi: 10.3324/haematol.2013.089425. Epub 2013 Aug 9.
Haematologica. 2014.
PMID: 23935021
Free PMC article.
Clinical Trial.